Benicar and Testim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benicar (olmesartan medoxomil) and Testim (testosterone). Common drug interactions include aortic calcification among females and erectile dysfunction among males.

The phase IV clinical study analyzes what interactions people have when they take Benicar and Testim. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Testim?

Testim has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 5,453 Testim users. Check the latest studies of Testim.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

48 people who take Benicar and Testim together, and have interactions are studied.

Benicar and Testim drug interactions.

What are the common drug interactions of Benicar and Testim, by gender? *:

female:

  1. Aortic calcification (aortic calcification sign of heart valve disease)
  2. Arrhythmia (irregular heartbeat)
  3. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  4. Asthenia (weakness)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Biliary colic
  7. Bladder disorder
  8. Blood glucose increased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Carotid arteriosclerosis (plaque deposition in artery)

male:

  1. Erectile dysfunction
  2. Fatigue (feeling of tiredness)
  3. Discomfort
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Headache (pain in head)
  6. Lung neoplasm (tumour of lung)
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  9. Metastases to adrenals (cancer spreads to adrenal gland of kidney)
  10. Metastases to bone (cancer spreads to bone)

What are the common drug interactions of Benicar and Testim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Bone density decreased
  5. Emotional distress
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis (bones weak and more likely to break)
  8. Pain
  9. Renal impairment (severely reduced kidney function)
  10. Aldolase increased

50-59:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Blood pressure fluctuation
  3. Chest discomfort
  4. Chronic kidney disease
  5. Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause)
  6. Cough
  7. Decreased appetite
  8. Depression
  9. Dilatation ventricular
  10. Dysarthria (speech disorder)

60+:

  1. Fatigue (feeling of tiredness)
  2. Abdominal pain
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Headache (pain in head)
  5. Lymphadenopathy (disease or enlargement of lymph nodes)
  6. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  7. Metastases to adrenals (cancer spreads to adrenal gland of kidney)
  8. Metastases to bone (cancer spreads to bone)
  9. Metastases to lung (cancer spreads to lung)
  10. Metastases to neck (cancer spreads to neck)

What are the existing conditions these people have? *

  1. Neoplasm Malignant (cancer tumour): 16 people, 33.33%
  2. Blood Testosterone Decreased: 12 people, 25.00%
  3. Pain: 4 people, 8.33%
  4. Hiv Infection: 4 people, 8.33%
  5. Diabetes: 4 people, 8.33%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.25%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.25%
  8. Erection Problems: 3 people, 6.25%
  9. Depression: 3 people, 6.25%
  10. Back Pain: 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and Testim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benicar and Testim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Testim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Testim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil and testosterone (the active ingredients of Benicar and Testim, respectively), and Benicar and Testim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: